Difference between revisions of "Example orders for ABVD in Hodgkin lymphoma"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "Original reference may be found" to "Original references may be found")
m (categories)
Line 45: Line 45:
 
'''Clinical scenario & comments:'''
 
'''Clinical scenario & comments:'''
 
*28 year-old gentleman with stage IIIAs Hodgkin lymphoma, treated with 6 cycles of ABVD.
 
*28 year-old gentleman with stage IIIAs Hodgkin lymphoma, treated with 6 cycles of ABVD.
 +
 +
[[Category:Example chemotherapy order sets]]

Revision as of 00:34, 20 September 2012

Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.


ABVD

ABVD: Adriamycin, Bleomycin, Vinblastine, Dacarbazine

Original references may be found at ABVD

Example regimen #1

  • Doxorubicin (Adriamycin) 25 mg/m2 IV on days 1 & 15
    • Given as IV push through running IV.
  • Bleomycin (Blenoxane) 10 units/m2 IV on days 1 & 15
    • For cycle 1 only: Bleomycin (Blenoxane) 1 unit test dose infused over 15 minutes. Observe patient for 60 minutes prior to administering the remainder of the full dose.
    • Infuse over 30 minutes after premedication with acetaminophen (Tylenol).
  • Vinblastine (Velban) 6 mg/m2 IV on days 1 & 15
    • Given as IV push through running IV.
  • Dacarbazine (DTIC) 375 mg/m2 IV on days 1 & 15
    • Given over 60 minutes, with rate adjustments as needed based on patient tolerability.

28-day cycles x 6 cycles

Supportive medications:

  • Acetaminophen (Tylenol) 650 mg PO 30 minutes prior to chemotherapy
  • Diphenhydramine (Benadryl) 25 mg PO 30 minutes prior to chemotherapy
  • Ondansetron (Zofran) 8 mg PO 30 minutes prior to chemotherapy
  • Aprepitant (Emend) 125 mg PO on days 1 & 15, 80 mg PO on days 2-3, 16-17
  • Dexamethasone (Decadron) 4 mg PO BID on days 1-3, 15-17

Hydration:

  • 500 ml NS and/or D5W at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS and/or D5W as needed for IV compatibility.

Monitoring:

  • On day 1 & 15 of each cycle: CBC with differential, absolute neutrophil count (ANC), comprehensive metabolic panel (including chem 10 & liver function tests (LFTs), LDH, uric acid
  • Physician to be notified if LFTs/bilirubin are outside normal limits, ANC <1000, platelets <100.
  • Check pulmonary function test (PFTs) with DLCO (diffusing capacity of the lung for carbon monoxide) prior to starting therapy and after 3-4 cycles of therapy. May perform PFTs as soon as after 2 cycles in high risk patients, such as recent smokers.
  • Smoking cessation for smokers given risk of bleomycin pulmonary toxicity.
  • Echocardiogram prior to start of therapy.
  • Restage with PET/CT after 3 cycles of therapy.

Outpatient medications:

  • Aprepitant (Emend) & Dexamethasone (Decadron) as described above in Supportive medications.
  • Trimethoprim/Sulfamethoxazole (Bactrim SS) 80/400 mg PO daily for PCP prophylaxis
  • Ondansetron (Zofran) 8 mg PO TID prn nausea
  • Prochlorperazine (Compazine) 10 mg PO Q6H prn nausea

Clinical scenario & comments:

  • 28 year-old gentleman with stage IIIAs Hodgkin lymphoma, treated with 6 cycles of ABVD.